Gynaecology & Obstetrics

20 learning units • 100 chapter sections • 200 explained questions. Assess pregnancy and reproductive health, recognise emergencies and plan respectful treatment, referral and follow-up.

Original RAHBAR study material for the Year 5 learning pathway. Clinical cases support supervised undergraduate learning. Treatment choices, doses and procedures must follow current local protocols and the responsible clinical team. References & further reading ↓

MODULE 20 / 20

Gynaecological Cancer & Integrated Follow-up

Recognise concerning symptoms and close the loop from investigation to specialist care.

Answer all 10 questions, then submit to see your score and explanations. This is a self-study exercise; results are not saved.

Question 01. Which pattern warrants assessment for possible gynaecological malignancy? A. A resolved isolated sneezeB. Persistent unexplained bleeding or a suspicious lesionC. Stable childhood freckles aloneD. A single brief hiccup

Question 02. How should unexplained postmenopausal bleeding be approached? A. Automatic reassurance as normal ageingB. Wait indefinitely for recurrenceC. Prompt assessment through the appropriate pathwayD. Only routine cervical screening

Question 03. Does HRT use automatically explain every episode of bleeding? A. Yes, all bleeding is harmlessB. Only if tablets are usedC. It excludes endometrial diseaseD. No, use the appropriate risk-based assessment

Question 04. Can cervical screening replace investigation of a suspicious cervix? A. YesB. Only after a recent negative screenC. Only if pain is absentD. No

Question 05. Persistent bloating and early satiety can prompt assessment for what? A. Ovarian and other abdominal pathologyB. Only uncomplicated menopause in every caseC. Definite pregnancy without testingD. No disease if pain is absent

Question 06. Is CA125 specific for ovarian cancer? A. Yes, without exceptionB. It identifies every cancer stageC. No, benign conditions can also raise itD. It replaces ultrasound

Question 07. Can a normal tumour marker alone exclude every ovarian cancer? A. YesB. Only if repeated onceC. NoD. Only after menopause

Question 08. What determines a gynaecological cancer treatment plan? A. One identical regimen for all sitesB. Only the referral dateC. Only a tumour-marker valueD. Site, stage, pathology, fitness and patient priorities

Question 09. When should fertility consequences of cancer treatment be discussed where feasible? A. Only after all treatment is finishedB. Never if treatment is urgentC. Only after symptoms recurD. Before treatment as part of specialist planning

Question 10. What completes the follow-up loop after a concerning investigation? A. Sending a request with no named reviewerB. Assuming silence means normalC. Results review, communication and confirmed appropriate next careD. Discharging despite persistent symptoms without advice

0 / 10 answered

References & Further Reading

Read the relevant guideline sections alongside these original clinical teaching cases. Local pathways, available services and individual patient factors determine care.

NICE NG12 — Suspected cancer: gynaecological referral pathways

Reference review: 28 September 2026. Consult current local protocols for prescribing, procedures and escalation.